Table 1 Baseline characteristics of the two treatment groups.
Variables | Salbutamol (n = 28) | Formoterol (n = 32) |
---|---|---|
Sex (M/F) | 14/18 | 13/15 |
Age (years), mean (SD) | 53.2 (15.0) | 56.4 (14.2) |
Duration of asthma (years), mean (SD) | 12.4 (8.4) | 10.4 (8.1) |
PEFR at baseline (l/min) | 100.8 | 119.3 |
F, female; M, male; PEFR, peak expiratory flow rate.